Ursprung des Netzwerks ersten Grades von Hajime Watanabe
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Generic | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hajime Watanabe
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| SUMITOMO CHEMICAL CO., LTD. | Chemicals: Specialty | Corporate Officer/Principal | |
| TOWA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| MORISHITA JINTAN CO., LTD. | Pharmaceuticals: Other | President | |
| TAKARA BIO INC. | Medical Specialties | Director/Board Member | |
| SOLASIA PHARMA K.K. | Pharmaceuticals: Major | Director/Board Member | |
| AnGes Euro Ltd. | Chief Executive Officer | ||
AnGes USA, Inc.
 AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer | |
| FUNPEP COMPANY LIMITED | Biotechnology | Director/Board Member | |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| Point Market KK | Director/Board Member | ||
| KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member |
Statistik
International
| Japan | 10 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
| Israel | 2 |
Sektoral
| Health Technology | 11 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 16 |
| Independent Dir/Board Member | 7 |
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 3 |
| President | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ei Yamada | 6 |
| Norikazu Eiki | 5 |
| Makoto Hara | 3 |
| Junichi Komamura | 3 |
| Tetsuji Yoneo | 1 |
| Jun Sakurai | 1 |
| Kazuo Suzuki | 1 |
- Börse
- Insiders
- Hajime Watanabe
- Unternehmensverbindungen
